The Government published its response to the Science and Technology Committee on the 10 December 2018. Good progress is being made on implementing the report\u2019s recommendations: for example, Public Health England will publish its latest annual evidence review on e-cigarettes by the end of March 2019 and NHS England is developing guidance on e-cigarettes for mental health trusts. The Department will continue to monitor progress as part of its monitoring of the delivery of the Tobacco Control Plan for England.<\/p>
<\/p>
The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes to reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.<\/p>
<\/p>
While the UK Government is a member of the EU it will continue to comply with the requirements of the EU\u2019s TPD. The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK\u2019s exit from the EU offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation\u2019s health.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-02-15", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "218246"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-15T11:10:04.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Electronic Cigarettes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what progress he has made on implementing the recommendations accepted by the Government in its response to the Science and Technology Committee's Seventh Report of Session 2017-19 on E-cigarettes, HC505.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1586", "label" : {"_value" : "Biography information for Adam Afriyie"} } , "tablingMemberConstituency" : {"_value" : "Windsor"} , "tablingMemberPrinted" : [{"_value" : "Adam Afriyie"} ], "uin" : "218245"} , {"_about" : "http://data.parliament.uk/resources/1055798", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1055798/answer", "answerText" : {"_value" : "
It is the responsibility of National Health Service trusts to have staffing arrangements in place that deliver safe and effective care. This includes recruiting the staff needed to support these levels and meet local needs.<\/p>
<\/p>
Dermatology is a highly competitive specialty training pathway and often oversubscribed. Nationally and locally there has been a 100% fill rate in dermatology training for the past four years. In May 2010 there were 464 full time equivalent dermatologists (doctors at the consultant grade) and in October 2018 there were 577 full time equivalent dermatologists \u2013 a 24% increase.<\/p>
<\/p>
My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce, including consideration of additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.<\/p>
<\/p>
Baroness Harding will present initial recommendations to the Department in spring 2019. A final workforce implementation plan will follow later in the year, taking into account the outcomes of the Spending Review.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-13T14:57:28.173Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Dermatology: Vacancies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of workforce shortages in the NHS on the delivery of dermatology services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4653", "label" : {"_value" : "Biography information for Stephen Morgan"} } , "tablingMemberConstituency" : {"_value" : "Portsmouth South"} , "tablingMemberPrinted" : [{"_value" : "Stephen Morgan"} ], "uin" : "217639"} , {"_about" : "http://data.parliament.uk/resources/1055966", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1055966/answer", "answerText" : {"_value" : "
We do not currently have clear estimates of the comparative cost of filling National Health Service vacancies with permanent rather than bank and agency staff. However, we do recognise that the cost of meeting the current level of staff shortages through bank and agency is greater than if those vacancies were filled by permanent staff. This is why we are working hard to boost NHS recruitment and reduce reliance on expensive agency workers.<\/p>
<\/p>
The Department has provided a 25% increase in funding available for training places for doctors and nurses from September 2018. There are currently over 52,000 nurses in undergraduate training, over 30,000 doctors in undergraduate training, and over 50,000 doctors in foundation and specialty postgraduate medical training. The Department is continuing to work closely with universities and stakeholders to ensure the uptake of additional training places.<\/p>
<\/p>
We are also working with NHS Improvement to implement a number of measures to reduce agency expenditure and ensure that trusts have effective and efficient banks. As a result of this work, total agency expenditure across NHS trusts in England has fallen from a peak of £3.6 billion in 2015/16 to £2.4 billion in 2017/18 \u2013 a £1.2 billion reduction.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-14T11:55:07.363Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Vacancies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to Answer of 30 January 2019 to Question 214461, what comparative estimate his Department has made of cost of filing 80 per cent of nursing and 85 per cent of medical vacancies with (a) the bank and agency staff and (b) permanent staff members.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"} , "tablingMemberPrinted" : [{"_value" : "Steve McCabe"} ], "uin" : "217436"} , {"_about" : "http://data.parliament.uk/resources/1055260", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1055260/answer", "answerText" : {"_value" : "
At the end of October 2018, 941,561 people were recorded as being in contact with National Health Service-funded mental health services and aged 18 and over. Therefore, the figure of 4,224, for people who were also recorded as having a speech related disability, represents 0.45% of the total.<\/p>
<\/p>
The data is sourced from the Mental Health Services Dataset (MHSDS). In the MHSDS User Guidance, the specific Code used to record speech related disabilities defines its use as appropriate in cases where \u201cthe patient has difficulty speaking or using language to communicate or make their needs known\u201d. The guidance is available at the following link:<\/p>
<\/p>
https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-sets/mental-health-services-data-set/mental-health-services-data-set-specifications-and-guidance<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-02-13", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-13T15:09:41.14Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mental Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 January 2019 to Question 209278 on Mental Health Services, (a) what proportion of people aged 18 and over in contact with National Health Service-funded secondary mental health services the 4,224 figure represents and (b) how his Department defines a speech related disability.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/155", "label" : {"_value" : "Biography information for Geraint Davies"}
}
, "tablingMemberConstituency" : {"_value" : "Swansea West"}
, "tablingMemberPrinted" : [{"_value" : "Geraint Davies"}
], "uin" : "216910"}
, {"_about" : "http://data.parliament.uk/resources/1054592", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1054592/answer", "answerText" : {"_value" : " Work with Israel on medicines is led by the British Embassy in Tel Aviv, which actively seeks opportunities to create United Kingdom-Israel partnerships in the medical field. An example of collaboration on medicines is BIRAX \u2013 a bilateral research fund active since 2015 with £10 million in mainly private funding for academic partnerships between the UK and Israel. The first three years focussed on regenerative medicine; the next stage is ageing with projects to be announced in the next few months.<\/p> <\/p> More broadly, the Embassy is working on other initiatives to foster UK-Israeli collaboration on health. For example, the UK Israel Tech Hub helps to create tech and innovation partnerships across several sectors, including healthcare.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-12T15:36:01.907Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Israel: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that advances in medicines by Israel are shared with the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "216252"}
, {"_about" : "http://data.parliament.uk/resources/1054561", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1054561/answer", "answerText" : {"_value" : " The NHS Long Term Plan, published on 7 January 2019, sets out a vital strategic framework to ensure that over the next 10 years the National Health Service will have the staff it needs.<\/p> <\/p> My Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce, including consideration of additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.<\/p> <\/p> Radiotherapy degree courses are three years in length, therefore students affected by the changes to the education funding system from 2017 will not have completed courses funded by loans to enable an assessment of the effect of the removal of bursaries on this profession.<\/p> <\/p> The Cancer Workforce Plan Phase 1, included a target of upskilling 300 more radiographers in image interpretation and reporting by 2021. Currently, 88 individuals have started training programmes towards this, 62 will start in January, and a further 150 during 2019/20.<\/p> <\/p> Phase 2 of the Cancer Workforce Plan will follow the Workforce Implementation Plan published later in 2019.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-07", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "216168"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-07T17:28:08.623Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radiography: Training"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent steps he has taken to tackle reductions in the number of applicants to radiography courses since the end of the NHS bursaries for those courses.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1591", "label" : {"_value" : "Biography information for Tim Farron"}
}
, "tablingMemberConstituency" : {"_value" : "Westmorland and Lonsdale"}
, "tablingMemberPrinted" : [{"_value" : "Tim Farron"}
], "uin" : "216167"}
, {"_about" : "http://data.parliament.uk/resources/1052190", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1052190/answer", "answerText" : {"_value" : " There has been no assessment of the effect of delays to the introduction of faecal immunochemical test to the Bowel Cancer Screening Programme on the diagnosis rates of Bowel Cancer at stage one, stage two, stage three and stage four, or on the mortality rates of bowel cancer in England.<\/p> <\/p> The National Health Service in England already has a world class bowel cancer screening programme for people aged 60-74 years, with survival rates improving year on year. Regular bowel cancer screening has been shown to reduce the risk of dying from bowel cancer by 16%, and around 60% of bowel cancer patients now survive five years or more compared to around 25% 40 years ago. Over 95% of men and women survive for five years or more if their bowel cancer is diagnosed at stage one.<\/p> <\/p> The NHS Long Term Plan includes a proposal to modernise the bowel cancer screening programme to detect more cancers earlier and faecal immunochemical testing at 120ug/g will be integrated into the programme from April 2019.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-07T15:19:47.553Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-31", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bowel Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department have made of the effect of delays to the introduction of the faecal immunochemical test to the Bowel Cancer Screening Programme on (a) the diagnosis rates of Bowel Cancer at (i) stage one, (ii) stage two, (iii) stage three and (iv) stage four and (b) the mortality rates of bowel cancer in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4056", "label" : {"_value" : "Biography information for Nic Dakin"}
}
, "tablingMemberConstituency" : {"_value" : "Scunthorpe"}
, "tablingMemberPrinted" : [{"_value" : "Nic Dakin"}
], "uin" : "215181"}
, {"_about" : "http://data.parliament.uk/resources/1052352", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1052352/answer", "answerText" : {"_value" : " Public Health England holds little information on emissions of perfluorooctanoic acid from waste incinerators, and no papers on any potential associated health effects.<\/p> <\/p> The available literature suggests that perfluorinated chemicals are destroyed as part of the incineration process, and nor does combustion lead to formation of perfluorooctanoic acid. As such incineration is not expected to be a source of this substance in the environment and there would not be a pathway through which health effects could occur.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-08T12:31:49.813Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-31", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Perfluorooctanoic Acid: Health Hazards"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what information Public Health England holds on research on the health effects of emissions of perfluorooctanoic acid from waste incinerators.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/252", "label" : {"_value" : "Biography information for Dr David Drew"}
}
, "tablingMemberConstituency" : {"_value" : "Stroud"}
, "tablingMemberPrinted" : [{"_value" : "Dr David Drew"}
], "uin" : "215079"}
, {"_about" : "http://data.parliament.uk/resources/1051294", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1051294/answer", "answerText" : {"_value" : " Public Health England (PHE) is not a statutory consultee under the planning regime. Local authority planners should consider consulting the Director of Public Health on any planning applications (including at the pre-application stage) that are likely to have a significant impact on the health and wellbeing of the local population or particular groups within it. This guidance can be viewed at the following links:<\/p> <\/p> https://www.gov.uk/guidance/consultation-and-pre-decision-matters#Statutory-consultees-on-applications<\/a><\/p> <\/p>